Submission Details
| 510(k) Number | K904022 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | August 30, 1990 |
| Decision Date | December 18, 1990 |
| Days to Decision | 110 days |
| Submission Type | Traditional |
| Review Panel | Pathology (PA) |
| Summary | — |
K904022 is an FDA 510(k) clearance for the NITRO BLUE TETRAZOLIUM REDUCTION, a Test, Leukocyte Alkaline Phosphatase (Class I — General Controls, product code GHD), submitted by Sigma Chemical Co. (St. Louis, US). The FDA issued a Cleared decision on December 18, 1990, 110 days after receiving the submission on August 30, 1990. This device falls under the Pathology review panel. Regulated under 21 CFR 864.7660.
| 510(k) Number | K904022 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | August 30, 1990 |
| Decision Date | December 18, 1990 |
| Days to Decision | 110 days |
| Submission Type | Traditional |
| Review Panel | Pathology (PA) |
| Summary | — |
| Product Code | GHD — Test, Leukocyte Alkaline Phosphatase |
| Device Class | Class I — General Controls |
| CFR Regulation | 21 CFR 864.7660 |